Ondansetron for postoperative nausea and vomiting

Therapy

Volumn 3, Issue 5, 2006, Pages 571-578

  Cohen, Ira Todd ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

5 HT3 receptor antagonists; Antiemetics; Ondansetron; Postoperative nausea and vomiting

Indexed keywords

7 HYDROXYONDANSETRON; 8 HYDROXYONDANSETRON; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; APREPITANT; BENZAMIDE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIMENHYDRINATE; DIPHENHYDRAMINE; DOLASETRON MESILATE; DOXORUBICIN; DROPERIDOL; DRUG METABOLITE; GRANISETRON; METOCLOPRAMIDE; MORPHINE; ONDANSETRON; PHENOTHIAZINE DERIVATIVE; PROMETHAZINE; PROPOFOL; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ARTICLE; BLURRED VISION; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DIZZINESS; DRUG COST; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG STRUCTURE; DYSPHORIA; EUPHORIA; EXTRAPYRAMIDAL SYMPTOM; HIGH RISK POPULATION; HUMAN; HYPOTENSION; INDIVIDUALIZATION; META ANALYSIS; NAUSEA AND VOMITING; NERVOUSNESS; NONHUMAN; POSTOPERATIVE NAUSEA AND VOMITING; QT PROLONGATION; SEDATION; SOMNOLENCE; SYSTEMATIC REVIEW; THIRST; TREMOR; XEROSTOMIA;

EID: 33750073166     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.1586/14750708.3.5.571     Document Type: Article

References (62)

1. Eberhatt LH, Morin AM, Wulf H, Geldner G. Patient preferences for immediate postoperative recovery. Br. J. Anaesth. 89, 760-761 (2002).
2. Jenkins K, Grady D, Wong J, Correa R, Armanious S, Chung F. Post-operative recovery: day surgery patients' preferences. Br. J. Anaesth. 86(2), 272-274 (2001).
3. Board T, Board R.: The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting. AORN J. 83(1), 209-216, 219-220 (2006).
4. Sennraj B, Shende D, Sadhasivam S, Ilavajady S, Jagan D. Management of post-strabismus nausea and vomiting in children using ondansetron: a value-based comparison of outcomes. Br. J. Anaesth. 89(3), 473-478 (2002).
5. Tang J, Wang B, White PF, Watcha MF, Qi J, Wender RH. The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting. Anesth. Analg. 86(2), 274-282 (1998).
6. Rashiq S, Edlund D, Dick BD. Utilities of the post-anesthesia state derived by the standard gamble method in surgical patients. BMC Med. Inform. Decis. Mak. 15, 6-8 (2006).
7. Cucchiaro G, Farrar JT, Guire JW, Li Y. What postoperative outcomes matter to pediatric patients? Anesth. Analg. 102(5), 1376-1382 (2006).
8. Richards CA. Andrews PL. Food refusal: a sign of nausea? J. Pediatr. Gastroenterol. Nutr. 38(2), 227-228 (2004).
9. Andrews PL, Hawthorn J. The neurophysiology of vomiting. Res. Clin. Gastroenterol. 2(9), 141-168 (1988).
10. Pisters KM, Kris MG. Treatment-related nausea and vomiting. In: Principles and Practice of Supportive Oncology. Berger A, Portenoy RK, Weissman DE (Eds). Lippincott-Raven Publishers, Philadelphia, PA, USA (1998).
11. Naylor RJ, Inall FC. The physiology and pharmacology of postoperative nausea and vomiting. Anaesthesia 49, 2-5 (1994).
12. Hasler WL. Nausea, gastroparesis, and aerophagia. J. Clin. Gastroenterol. 39(5), 223-229 (2005).
13. Eberhart LH, Geldner G, Kranke P et al. The development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients. Anesth. Analg. 99(6), 1630-1637 (2004).
14. Apfel CC, Kranke P, Eberhart LH, Roos A, Roewer N. Comparison of predictive models for postoperative nausea and vomiting. Br. J. Anaesth. 88(2), 234-240 (2002).
15. Biedler A, Wermelt J, Kunitz O et al. A risk adapted approach reduces the overall institutional incidence of postoperative nausea and vomiting. Can. J. Anaesth. 51(1), 13-19 (2004).
16. Gan TJ, Meyer T, Apfel CC et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth. Analg. 97(1), 62-71 (2003).
17. Kranke P, Morin AM, Roewer N, Wulf H, Eberhart LH. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth. Analg. 95(1), 133-143 (2002).
18. Kranke P, Morin AM, Roewer N, Eberhart LH: Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Acta Anaesthesiol. Scand. 46(3), 238-44 (2002).
19. Moser JD, Caldwell JB, Rhule FJ. No more than necessary: safety and efficacy of low-dose promethazine. Ann. Pharmacother. 40(1), 45-48 (2006).
20. Domino KB, Anderson EA, Polissar NL, Posner KL. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesth. Analg. 88(6), 1370-1379 (1999).
21. Eberhart LH, Morin AM, Seeling W, Bothner U, Georgieff M. Meta-analysis of controlled randomized studies on droperidol for prevention of postoperative phase vomiting and nausea. Anasthesiol. Intensivmed. Notfallmed. Schmerzther. 34(9), 528-536 (1999).
22. Kovac AL. Benefics and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting. Drug Saf. 26(4), 227-259 (2003).
23. Henzi I, Walder B, Tramer MR. Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. Br. J. Anaesth. 83(5), 761-771 (1999).
24. Henzi I, Wilder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth. Analg. 90(1), 186-194 (2000).
25. Goldman AC, Govindaraj S, Rosenfeld RM. A meta-analysis of dexamethasone use with tonsillectomy. Otolaryngol. Head Neck Surg. 123(6), 682-686 (2000).
26. Kazemi-Kjellberg F, Henzi I, Tramer MR. Treatment of established postoperative nausea and vomiting: a quantitative systematic review. BMC Anesthesiol. 1(1), 2 (2001).
27. Gupta A, Wu CL, Elkassabany N, Krug CE, Parker SD, Fleisher LA. Does the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery? A systematic review of randomized controlled trials. Anesthesiology 99(2), 488-495 (2003).
28. Kovac AL. Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies. Ann. Pharmacother. 40(5), 873-887 (2006).
29. Habib AS, Gan TJ. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report. J. Clin. Anesth. 17(1), 62-65 (2005).
30. Butler A, Hill JM, Ireland SJ, Jordan CC, Tyers MB. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br. J. Pharmacol. 94(2), 397-412 (1988).
31. Gan TJ. Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same? CNS Drugs 19(3), 225-238 (2005).
32. Spahr-Schopfer IA, Lerman J, Sikich N, Palmer J, Jorch U. Pharmacokinetics of intravenous ondansetron in healthy children undergoing ear, nose, and throat surgery. Clin. Pharmacol. Ther. 58(3), 316-321 (1995).
33. Pritchard JF. Ondansetron metabolism and pharmacokinetics. Semin. Oncol. 19(4), 9-15 (1992).
34. Pritchard JF, Bryson JC, Kernodle AE, Benedetti TL, Powell JR. Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers. Clin. Pharmacol. Ther. 51(1), 51-55 (1992).
35. Candiotti KA, Birnbach DJ, Lubarsky DA et al. The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis? Anesthesiology 102(3), 543-549 (2005).
36. Blower PR. Related 5-HT3-receptor antagonists and the cytochrome P450 system: clinical implications. Cancer J. 8(5), 405-414 (2002).
37. Kaiser R, Sezer O, Papies A et al. Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes. J. Clin. Oncol. 20(12), 2805-2811 (2002).
38. Finn AL. Toxicity and side effects of ondansetron. Semin. Oncol. 19(4), 53-60 (1992).
39. Tucker ML, Jackson MR, Scales MD et al. Ondansetron: pre-clinical safety evaluation. Eur. J. Cancer Clin. Oncol. 25(1), 79-93 (1989).
40. Stables R, Andrews PL, Bailey HE et al. Antiemetic properties of the 5HT3-receptor antagonist, GR38032F. Cancer Treat. Rev. 14(3-4), 333-336 (1987).
41. Eglen RM, Lee CH, Smith WL, Johnson LG, Whiting RL, Hegde SS. A novel and potent 5-HT3 receptor antagonist, in vitro and in vivo. J. Pharmacol. Exp. Ther. 266(1), 535-543 (1993).
42. Butler A, Hill JM, Ireland SJ, Jordan CC, Tyers MB. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br. J. Pharmacol. 94(2), 397-412 (1988).
43. Figueredo E, Canosa L. Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness in patients with and without a previous history of motion sickness. Eur. J. Anaesthesiol. 16(8), 556-564 (1999).
44. Figueredo E, Canosa L. Prophylactic ondansetron for postoperative emesis. Meta-analysis of its effectiveness in patients with previous history of postoperative nausea and vomiting. Acta Anaesthesiol. Scand. 43(6), 637-644 (1999).
45. Tramer MR, Walder B. Efficacy and adverse effects of prophylactic antiemetics during patient-controlled analgesia therapy: a quantitative systematic review. Anesth. Analg. 88(6), 1354-1361 (1999).
46. McQuay HJ, Moore RA. Postoperative analgesia and vomiting, with special reference to day-case surgery: a systematic review. Health Technol. Assess. 2(12), 1-236 (1998).
47. Trainer MR, Reynolds DJ, Moore RA, McQuary HJ. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 87(6), 1277-1289 (1997).
48. Khalil SN, Roth AG, Cohen IT, Simhi E, Ansermino JM et al. A double-blind comparison of intravenous ondansetron and placebo for preventing postoperative emesis in 1- to 24-month-old pediatric patients after surgery under general anesthesia. Anesth. Analg. 101(2), 356-361 (2005).
49. Charbit B, Albaladejo P, Funck-Brentano C, Legrand M, Samain E, Marty J. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 102(6), 1094-1100 (2005).
50. Navari RM, Koeller JM. Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists. Ann. Pharmacother. 37(9), 1276-1286 (2003).
51. Kuryshev YA, Brown AM, Wang L, Benedict CR. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J. Pharmacol. Exp. Ther. 295(2), 614-620 (2000).
52. Scuderi PE. You (still) can't disprove the existence of dragons. Anesthesiology 102(6), 1081-1082 (2005).
53. van den Bosch JE, Bonsel GJ, Moons KG, Kalkman CJ. Effect of postoperative experiences on willingness to pay to avoid postoperative pain, nausea, and vomiting. Anesthesiology 104(5), 1033-1039 (2006).
54. Pueyo FJ, Lopez-Olaondo L, Sanchez-Ledesma MJ, Ortega A, Carrascosa F. Cost-effectiveness of three combinations of antiemetics in the prevention of postoperative nausea and vomiting. Br. J. Anaesth. 91(4), 589-592 (2003).
55. Olutoye O, Jantzen EC, Alexis R, Rajchert D, Schreiner MS, Watcha MF. A comparison of the costs and efficacy of ondansetron and dolasetron in the prophylaxis of postoperative vomiting in pediatric patients undergoing ambulatory surgery. Anesth. Analg. 97(2), 390-396 (2003).
56. Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N. Engl. J. Med. 350(24), 2441-2451 (2004).
57. Jordan K. Neurokinin-1-receptor antagonists: a new approach in antiemetic therapy. Onkologie 29(1-2), 39-43 (2006).
58. Diemunsch P, Schoeffler P, Bryssine B et al. Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery. Br. J. Anaesth. 82(2), 274-276 (1999).
59. Streitberger K, Diefenbacher M, Bauer A et al. Acupuncture compared to placebo-acupuncture for postoperative nausea and vomiting prophylaxis: a randomized placebo-controlled patient and observer blind trial. Anaesthesia 59(2), 142-149 (2004).
60. White PF, Issioui T, Hu J et al. Comparative efficacy of acustimulation (ReliefBand) versus ondansetron in combination with droperidol for preventing nausea and vomiting. Anesthesiology 97(5), 1075-1081 (2002).
61. Coloma M, White PF, Ogunnaike BO et al. Comparison of acustimulation and ondansetron for the treatment of established postoperative nausea and vomiting. Anesthesiology 97(6), 1387-1392 (2002).
62. Joo HS, Perks WJ. Sevoflurane versus propofol for anesthetic induction: a meta-analysis. Anesth. Analg. 91(1), 213-219 (2000).